Last quarter (Q3 2023), Cytosorbents's total revenue was $8.81M, an increase of 36.33% from the same quarter last year. In Q3, Cytosorbents's net income was $-9.19M. See Cytosorbents’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 18.23M	$ 34.69M	$ 43.17M	$ 39.45M	$ 24.95M	$ 22.50M
Cost of Revenue	$ 14.23M	$ 13.96M	$ -11.05M	$ 11.05M	$ 7.36M	$ 7.49M
Gross Profit	$ 4.00M	$ 20.73M	$ 32.12M	$ 28.40M	$ 17.59M	$ 15.01M
Operating Expense	$ 51.00M	$ 52.25M	$ -54.86M	$ 38.77M	$ 36.56M	$ 30.60M
Operating Income	$ -47.00M	$ -31.52M	$ -65.91M	$ -10.37M	$ -18.97M	$ -15.58M
Net Non Operating Interest Income Expense	$ -157.84K	$ 132.60K	$ 28.01K	$ -1.20M	$ -1.03M	$ -1.46M
Other Income Expense	$ -18.84M	$ 67.30K	$ -43.17M	$ 2.61M	$ -350.37K	$ -784.75K
Pretax Income	$ -24.53M	$ -33.91M	$ -25.29M	$ -8.96M	$ -20.36M	$ -17.83M
Tax Provision	$ -1.09M	$ -1.09M	$ -736.00K	$ -1.13M	$ -1.09M	$ -619.55K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -23.44M	$ -32.81M	$ -24.56M	$ -7.84M	$ -19.27M	$ -17.21M
Basic EPS	$ -0.53	$ -0.75	$ -0.57	$ -0.20	$ -0.60	$ -0.56
Diluted EPS	$ -0.53	$ -0.75	$ -0.57	$ -0.20	$ -0.60	$ -0.56
Basic Average Shares	$ 175.64M	$ 43.57M	$ 43.36M	$ 38.82M	$ 32.26M	$ 30.72M
Diluted Average Shares	$ 175.06M	$ 43.57M	$ 43.36M	$ 38.82M	$ 32.26M	$ 30.72M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 65.23M	$ 66.21M	$ -65.91M	$ 49.82M	$ 43.92M	$ 38.09M
Net Income From Continuing And Discontinued Operation	$ -23.44M	$ -32.81M	$ -24.56M	$ -7.84M	$ -19.27M	$ -17.21M
Normalized Income	$ -4.84M	-	-	$ -10.12M	$ -18.93M	$ -16.45M
Interest Expense	-	-	-	$ 1.20M	$ 1.03M	$ 1.46M
EBIT	$ -24.52M	$ -33.91M	$ -25.29M	$ -7.76M	$ -19.32M	$ -16.37M
EBITDA	$ -21.45M	$ -32.77M	$ -24.17M	$ -7.10M	$ -18.74M	$ -15.98M

Currency in USD

Cytosorbents Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing